2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
Joseph M. Braun(Brown University), D. van der Heijde(Leiden University), Marjatta Leirisalo‐Repo(University of Helsinki), Rosaline van den Berg(GGD Zuid Limburg), Pál Géher(Semmelweis University), Ewa Stanisławska‐Biernat(National Institute of Geriatrics, Rheumatology and Rehabilitation), Paul Emery(University of Leeds), Daniel Wendling(Centre Hospitalier Universitaire de Besançon), Tore K Kvien(Diakonhjemmet Hospital), Hanne Dagfinrud(University of Oslo), Ignazio Olivieri(Ospedale Madonna Delle Grazie), Barend J. van Royen(Emma Kinderziekenhuis), Eduardo Collantes‐Estévez(Hospital Universitario Reina Sofía), Salih Özgöçmen(Tokat Gaziosmanpaşa Üniversitesi), Merryn Jongkees, M. Hammoudeh(Hamad Medical Corporation), Xenofon Baraliakos(Rheumazentrum Ruhrgebiet), Walter P. Maksymowych(University of Alberta), Karel Pavelká(Institute of Rheumatology), MA Khan(Case Western Reserve University), RD Inman(Hospital for Special Surgery), Maxime Dougados(Délégation Paris 5), Ben A. C. Dijkmans(Vrije Universiteit Amsterdam), R Burgos-Vargas(Hospital General de México), Heinrich Boehm(Zentralklinik Bad Berka), J. Sieper(Charité - Universitätsmedizin Berlin), C van Drogen, Uta Kiltz(Rheumazentrum Ruhrgebiet)
Cited by 988
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
|The Lancet|2004|1.8k
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
|Annals of the Rheumatic Diseases|2017|1.6k
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis
|Annals of the Rheumatic Diseases|2013|1.4k